SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-049468
Filing Date
2023-09-25
Accepted
2023-09-22 17:36:19
Documents
13
Period of Report
2023-09-18
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K amam-20230918.htm   iXBRL 8-K 74576
  Complete submission text file 0000950170-23-049468.txt   233768

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT amam-20230918_pre.xml EX-101.PRE 14510
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT amam-20230918.xsd EX-101.SCH 3707
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT amam-20230918_def.xml EX-101.DEF 14450
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT amam-20230918_lab.xml EX-101.LAB 18741
7 EXTRACTED XBRL INSTANCE DOCUMENT amam-20230918_htm.xml XML 6520
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Filer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40505 | Film No.: 231272592
SIC: 2836 Biological Products, (No Diagnostic Substances)